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Preconception care for diabetic women for
improving maternal and fetal outcomes:
a systematic review and meta-analysis
Hayfaa A Wahabi*, Rasmeia A Alzeidan, Ghada A Bawazeer, Lubna A Alansari, Samia A Esmaeil
Abstract
Background: Preexisting diabetes mellitus is associated with increased risk for maternal and fetal adverse
outcomes. Despite improvement in the access and quality of antenatal care recent population based studies
demonstrating increased congenital abnormalities and perinatal mortality in diabetic mothers as compared to the
background population. This systematic review was carried out to evaluate the effectiveness and safety of
preconception care in improving maternal and fetal outcomes for women with preexisting diabetes mellitus.
Methods: We searched the following databases, MEDLINE, EMBASE, WEB OF SCIENCE, Cochrane Library, including
the CENTRAL register of controlled trials and CINHAL up to December 2009, without language restriction, for any
preconception care aiming at health promotion, glycemic control and screening and treatment of diabetes
complications in women of reproductive age group with type I or type II diabetes. Study design were trials
(randomized and non-randomized), cohort and case-control studies. Of the 1612 title scanned 44 full papers were
retrieved of those 24 were included in this review. Twelve cohort studies at low and medium risk of bias, with
2502 women, were included in the meta-analysis.
Results: Meta-analysis suggested that preconception care is effective in reducing congenital malformation, RR 0.25
(95% CI 0.15-0.42), NNT17 (95% CI 14-24), preterm delivery, RR 0.70 (95% CI 0.55-0.90), NNT = 8 (95% CI 5-23) and
perinatal mortality RR 0.35 (95% CI 0.15-0.82), NNT = 32 (95% CI 19-109). Preconception care lowers HbA1c in the
first trimester of pregnancy by an average of 2.43% (95% CI 2.27-2.58). Women who received preconception care
booked earlier for antenatal care by an average of 1.32 weeks (95% CI 1.23-1.40).
Conclusion: Preconception care is effective in reducing diabetes related congenital malformations, preterm
delivery and maternal hyperglycemia in the first trimester of pregnancy.
Background
Diabetes mellitus (DM) is a global public health problem
with expected 300 million diabetics by the year 2030
worldwide [1]. In many areas around the globe including
the West as well as many developing and Middle Eastern
countries, diabetes has become a major health burden
affecting young adults and women in their reproductive
age [2,3].
Despite improved access and quality of antenatal care,
women with pre-gestational diabetes and their fetuses are
at increased risk of developing serious complications
compared with the non-diabetic pregnant women,
including spontaneous abortion, preterm labor, hyperten-
sive disorders, and delivery by cesarean section [4,5]. In
the recent report of The Confidential Inquiry into Mater-
nal and Child Health (CEMACH) from England, Wales
and Northern Ireland, the perinatal mortality in mothers
with type 1 and type 2 DM is four times higher and the
risk of congenital malformation in the babies of women
with diabetes is nearly three times greater [4]. Similar
reports from North America showed no significant
improvement in fetal and neonatal outcomes of women
with pre-gestational diabetes between 1988 and 2002 [6]
despite the Saint Vincent Declaration in 1989 which sets
a healthcare goal to improve the outcome of pregnancies
in diabetic women [7].
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Similar reports from the Middle East showed higher
rate of perinatal mortality in diabetic as compared to
non-diabetic women [8].
Many of the complications of DM during pregnancy
can be prevented by optimizing maternal health in the
preconception period. Glycemic control is one of the
most important aspects of preconception care (PCC) [9];
however other aspects such as folic acid supplementation,
smoking cessation, screening and treatment of diabetes
complications and discontinuing teratogenic medication,
are as important for improving maternal and fetal out-
comes [10].
We carried out a systematic review to assess the effec-
tiveness and safety of PCC in improving maternal and
fetal outcomes for women with preexisting type 1 or
type 2 DM.
Methods
Type of studies
We included in this review randomized trials (including
cluster and quasi randomized studies) and cohort and
case control studies, comparing the frequency of mater-
nal and fetal adverse outcomes in diabetic women who
received PCC with those who did not receive PCC.
Type of participants
Women of reproductive age with preexisting type 1 or
type 2 diabetes mellitus who were not pregnant at the
time of intervention.
Type of intervention
For the purpose of this review PCC is defined as the fol-
lowing either as sole intervention or in combination
1. Glycemic control by insulin and/or diet aiming at
fasting blood glucose ≤5.7 mmol/l or/and postpran-
dial blood glucose ≤7.8 mmol/l and/or glycosylated
hemoglobin A (HbA1C) ≤7.0%)
2. Women counseling and/or education about dia-
betes complications during pregnancy, the impor-
tance of glycemic control and self monitoring of
blood glucose level.
3. Preconception screening and treatment of compli-
cations of diabetes
4. The use of contraception until optimization of
glycemic control is achieved
5. Intake of multivitamin or folic acid in the precon-
ception period.
Type of outcome
Maternal outcomes
1. HbA1C level in the first trimester.
2. Gestation age at the time of the first visit to
antenatal care clinic (booking visit).
3. Pregnancy complications including spontaneous
abortion, termination of pregnancy due to congenital
malformations, polyhydramninos, pre-eclampsia, pre-
term delivery (before 37 completed weeks from the
last menstrual period) and induction of labour due
to complication of diabetes.
4. Delivery by cesarean section or instrumental
delivery.
5. Maternal hypoglycemia in the first trimester or
any other adverse effect reported by the authors.
Neonatal outcomes
1. Congenital malformation related to maternal
diabetes
2. Total mortality (stillbirth and neonatal death).
3. Birth trauma
4. Admission to neonatal intensive care unit (NICU).
5. Respiratory distress syndrome (RDS)
6. Macrosomia (birth weight ≥4 kg for term infants
or birth weight ≥90th percentile for the gestation
age)
7. Small for gestational age (SGA) (birth weight
below the 10th percentile for the gestational age).
8. Shoulder dystocia.
Exclusion criteria
We excluded from this review reports which are not of
comparative design and reports of conference proceed-
ings or abstracts when there is no complete description
of the trial or study.
Search strategy
The search strategy was developed in consultation of an
information retrieval specialist. We searched the follow-
ing databases, MEDLINE (1966-December 2009),
EMBASE (1980-December2009), WEB OF SCIENCE
(Science citation index-1970-December 2009), Cochrane
Library up to the latest issue 2009, including the CEN-
TRAL register of controlled trials and CINHAL (Cumu-
lative Index to Nursing & Allied Health 1982 -December
2009). (For full search strategy see Additional file 1:
Appendix 1)
We reviewed the reference list of all relevant studies
for any potential study not retrieved by the search strat-
egy. Unpublished reports were not actively sought and
there was no language limitation.
Identification of included studies
All titles and abstracts retrieved by the electronic search
were screened independently by three reviewers and the
studies which clearly did not meet the inclusion criteria
were excluded. Copies of the full text of potentially
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relevant studies and trials were obtained and their elig-
ibility was assessed independently by two reviews. Dif-
ferences between reviewers were resolved by discussion
or by consulting a third reviewer.
Data extraction and studies assessment
Three authors extracted data from the included studies
using a designed form. The accuracy of the extracted
data was checked by two other reviewers.
The Newcastle Ottawa Scale (NOS) was used for the
assessment of cohort, case control studies and non-rando-
mized trials [11]. Risk of bias in each study, was assigned
according to the number of items on the NOS judged
to be inadequate. We considered low risk of bias when
one item is inadequate, medium risk of bias when up to
three items are inadequate and high risk of bias when
more than three items are inadequate. Data analysis was
carried out with the use of Review Manager Software 5.0
(Cochrane Collaboration, Oxford, United Kingdom).
Meta-analysis was performed for studies with similar
design and type of intervention, which we assessed to be
at medium or low risk of bias using the fixed effect
model. Heterogeneity is considered high when I2 >50%
and explanation was attempted however subgroup analy-
sis was not possible in most of the cases due to the
small number of studies. Pooled data were presented as
risk ratio (RR) with 95% confidence intervals (95% CI)
for dichotomous outcomes and as the means difference
with 95% confidence intervals for continuous outcomes.
Results
The search retrieved 1612 potentially relevant titles of
which the full papers of 44 relevant reports were
reviewed (Figure 1). A total of 24 reports of 20 studies
were included in this review [10,12-34]. (Three articles
described the same cohort study with two interim
[17,18] and one final report [19], one study reported the
outcomes for the same cohort in two articles [10,29]
and two articles report the outcomes of one cohort with
one interim [31] and one final report [28]).
Twenty studies were excluded, 16 of them were
excluded because they did not meet the inclusion cri-
teria, 2 reports were of conference proceedings and in 2
studies data were not extractable (Additional file 1:
Appendix 2).
Of the included studies, only one was a controlled
trial, 11 studies were prospective cohort studies, 7 stu-
dies were retrospective cohort studies and one was a
case control study (Tables 1-4).
Assessment of the methodological quality of the included
studies
The cohort studies included in this review (Table1 & 2)
had adequate description of participants including
description of some confounding factors such as the fre-
quency of renal and vascular complications of diabetes
between the PCC group and the control group. However
all studies did not address the effect of the presence of
confounding factors on the outcomes except for 2
reports which used regression analysis to evaluate the
effectiveness of the PCC [10,29].
In most of the cohort studies blinding of the control
group was adequate because they were recruited after
pregnancy when they attended for antenatal care, except
for 2 studies [24,28], in which inadequate blinding of
the control group cannot be excluded because they were
informed about the importance of the PCC and were
invited to attend. All participants received the same
antenatal and post natal care except for one study [24]
where participants were followed up in different health
settings.
All cohort studies had adequate follow up for partici-
pants except for one study in which 52% of the PCC
group were lost to follow up [26]. The assessors of the
outcomes were not blinded to the participants’ alloca-
tion except in one study [25].
Some of the studies at high risk of bias were initially
designed to assess aspects of PCC other than its effec-
tiveness in improving maternal and fetal outcomes,
hence the poor methodological design when assessed
with the NOS [16,22,30].
PCC in all the cohort studies included control and self
monitoring of blood glucose except for one which was
designed to examine the effectiveness of preconception
counseling on fetal and neonatal outcomes [30]. In addi-
tion to glycemic control, 4 studies included screening
and treatment of complications of diabetes in the PCC
program [16,19,21,22]. Only one cohort study (two
reports) had comprehensive PCC program including,
control and self monitoring of blood glucose, folic acid
supplementation, smoking cessation advice and disconti-
nuation of teratogenic drugs [10,29].
One case-control study was included in this review
[13] (Table 3). It examined the effectiveness of multivi-
tamin supplementation in the preconception period in
preventing diabetes related congenital abnormalities.
The study is at medium risk of bias due to possibility of
recall bias during the interview of the mothers and the
possibility that interviewers were not blinded to the
outcome.
One trial was included in this review [12] (Table 4).
The design of the trial was not clear as authors reported
it as a randomized trial but the method for randomiza-
tion was not described. There was no allocation con-
cealment and lack of blinding introduced bias because
both groups were aware of the importance of the glyce-
mic control and the complications of diabetes during
pregnancy.
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Only 2 studies in this review evaluated maternal hypo-
glycemia, as an adverse effect of PCC [10,28].
Outcome of PCC
Similarity of participants, intervention, and outcomes in
addition to the score of low or medium risk of bias,
made meta-analysis possible for12 cohort studies
[10,15,16,19-21,23,25,26,28,32,33] with 2502 participants
(Tables 1, 2 & 5 and Figures 2,3,4,5,6, and 7). Both
dichotomous and continuous data were pooled but only
when standard deviation and similar units were available
for continuous data. Studies which were at high risk of
bias or of a design other than cohort were excluded
from the meta-analysis.
Meta-analysis suggested that preconception care is
effective in reducing congenital malformation, RR 0.25
(95% CI 0.15-0.42), NNT17 (95% CI 14-24), preterm
delivery, RR 0.70 (95% CI 0.55-0.90), NNT= 8 (95% CI
5-23) and perinatal mortality RR 0.35 (95% CI 0.15-
0.82), NNT= 32 (95% CI 19-109) (Figures 2, 3, and 4).
Meta-analysis of 5 trials show that PCC lowers
HbA1C in the first trimester of pregnancy by an average
of 2.43% (95% CI 2.27-2.58) and while there is high het-
erogeneity (I2= 97%) this variation is in the size of the
effect rather than the direction (Figure 5).
Women who received PCC booked earlier during preg-
nancy for antenatal care compared to women who did not,
by an average of 1.32 week (95% CI 1.4-1.23) (Figure 6)
Figure 1 Process of selection of the studies for the systematic review.
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Table 1 Characteristics of included Prospective Cohort Studies
Study/Year
of
Publication
Reference
(country)
Participants Intervention Outcome Risk of Bias (Notes)
Garcia-
Patterson
1997 [20]
(Spain)
66 participants with type I and
type II who attended the
preconception clinic and 119
participants with type I and type
II diabetes who did not.
PCC included intensive insulin
therapy, self-monitoring of
blood glucose and dietary
advice
The HA1C was significantly
better in the PCC group than for
the NPCC group (p = 0.01). The
rate of cesarean section was
higher in the PCC group than
the NPCC. No differences were
observed in abortion, Pre-
eclampsia and preterm labor.
Small for gestation age was
more in the NPCC.
Medium (The baseline
characteristics in relation to the
vasculopathy are different. No
blinding for the outcome
assessment).
Herman
1999 [22]
(USA)
24 women with type I diabetes
who attended the
preconception clinic, and 74
women with type I diabetes
who did not attend the
preconception clinic.
PCC included education,
counseling, glycemic control,
and assessment of
complications of diabetes
such as nephropathy and
retinopathy
Women who had PCC had
significantly more spontaneous
abortion, significantly lower level
of HA1C at booking and
throughout pregnancy and
significantly heavier infants at
birth than NPCC group (p <
0.05). There was no significant
difference between the two
groups in the frequency of
infants with congenital
malformations, gestation age at
delivery or frequency of
neonatal admission to the
intensive care unit.
High (The study was not
designed to assess the clinical
outcomes of the preconception
care but the differences in the
socio-demographic features
between the groups who attend
the preconception care and
those who did not. The target
level for the glycemic control
was not clear and the absolute
level of Hb A1C at booking and
all through pregnancy for the
study and the control groups
was not mentioned)
Jaffiol 2000
[23]
(France)
21 IDDM attended the pre-
conception care and 40 did not
attend
PCC included education,
glycemic control self
monitoring of blood glucose
and Contraception
The investigated outcomes
included polyhydramninos, pre-
eclampsia, premature deliver,
rate of cesarean section, rate of
spontaneous and therapeutic
abortion, perinatal and neonatal
mortality, neonatal
hypoglycemia and birth trauma.
Significant reduction in the total
fetal loss, neonatal mortality and
congenital malformations (p <
0.05), the level of maternal HA1C
in the 1st trimester (p < 0.05)
and total adverse obstetrics
complications (p < 0.05)
Low (good report, clear
intervention description, the
comparative groups received
same antenatal intervention. No
blinding for outcome
assessment)
Jensen
1986 [24]
(Denmark)
9 women with insulin
dependent diabetes had
preconception care and 11
women with insulin dependent
diabetic who did not receive
preconception care.
PCC included continuous
insulin infusion initiated 2
months prior to conception
No significant difference in
congenital malformations and
HA1C level, between the two
groups
High (small number of study
and control group, many
differences in the baseline
characteristics in the severity of
diabetes, 5 of the 11 control
women were treated in the
diabetic clinic in the hospital
before pregnancy so they knew
about the importance of
glycemic control both groups
have the same HA1C levels in
early pregnancy)
Kitzmiller
1991 [25]
(USA)
84 women in preconception
care and 110 women had no
preconception care
PCC included glycemic and
dietary control education,
exercise and contraception.
The frequency of congenital
abnormalities in the PCC group
was 1.2% compared to 10.9% in
the NPCC group (p < 0.05). There
were 12 spontaneous abortion in
the preconception care group
and 14 in the group who
received no preconception care.
Low (good report clear
methodology)
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Table 1 Characteristics of included Prospective Cohort Studies (Continued)
Rosenn
1991 [26]
(USA)
28 women in the preconception
group and 71 in the control
group
PCC included dietary advice
and glycemic control
HA1C concentration in the PCC
group was lower than in the
NPCC group (p < 0.0008).
Spontaneous abortion rate was
lower (p < 0.04) and there was
no congenital malformations in
either group.
Medium (52% of preconception
care patients dropped out, no
blinding in the assessment of
the outcome)
Temple
2006a [10]
2006b [29]
(UK)
110 women with type I diabetes
attended the preconception
care clinic and 180 women with
type I diabetes did not attend
the preconception care clinic
PCC included: Glycemic
control, folic acid
supplementation, smoking
cessation, education.
There was significant
improvement in the outcome
between the PCC group and the
NPCC group in the rate of
spontaneous abortion (p <
0.056) and in the rate of
preterm delivery (p < 0.02). The
rate of congenital malformations
was lower in PCC group
compared to the NPCC group (p
< 0.065). the adverse outcome
including malformations, still
birth and neonatal death were
significantly more in the latter
group than the former one (p <
0.026)
Low (Baseline characteristics in
both groups were similar; the
prospective nature of the study
ascertained the completeness of
the follow up, the completeness
of the baseline and the
outcome data. Use of
appropriate statistical tests such
as logistic regression analysis
confirmed the association
between the preconception care
and outcomes).
Willhoite
1993 [30]
(USA)
62 women with either type I or
type II diabetes who received
preconception counseling and
123 women with either type I or
type II diabetes who did not
receive preconception
counseling
PCC included counseling by
health professional the control
group received no counseling.
PCC group had significantly less
perinatal mortality than the
NPCC group (OR3.9 CI 1.2-13.9)
and insignificantly less
congenital malformations (OR
4.2 CI 0.5-29.7)
High (Base line characteristics of
the two groups were
significantly different in age,
duration of diabetes and
smoking all are confounding
factors for the outcomes. The
two groups did not receive the
same antenatal intra-partum and
postnatal care. The assessor of
the congenital malformation
was not blinded)
Boulot
2003 [33]
(France)
172 women with either type I or
type II diabetes who received
PCC and 260 women with
either type I or type II diabetes
who did not receive PCC
PCC included education,
assessment of diabetes
complications glycemic
control self monitoring of
blood glucose and
Contraception
PCC group had significantly less
perinatal mortality than the
NPCC group, (p < 0.005) for type
1 diabetics and significantly less
congenital malformations, (p <
0.005) for type 1 diabetics
Low (cases and control were
well defined and comparable,
selection bias is unlikely as
consecutive cases were enrolled,
the prospective nature of the
study ascertained the
completeness of the follow up,
the completeness of the
baseline and the outcome data)
Galindo
2006 [32]
(Spain)
15 women with pre-existing
diabetes received PCC and 112
women with pre-existing
diabetes did not receive PCC.
PCC included education,
glycemic control self
monitoring of blood glucose
The frequency of congenital
abnormalities in the PCC group
was 3/15 compared to 14/112 in
the NPCC group. There was 1
spontaneous abortion in the
PCC group and 9 in the group
who received no PCC.
Low (cases and control were
well defined and comparable,
selection bias is unlikely as
consecutive cases were enrolled,
the prospective nature of the
study ascertained the
completeness of the follow up,
the completeness of the
baseline and the outcome data)
Garcia
Ingelmo
1998 [34]
(Spain)
12 women with pre-existing
diabetes received PCC and 12
women with pre-existing
diabetes did not receive PCC
PCC glycemic control. The frequency of congenital
abnormalities in the PCC group
was 3/12 compared to 2/12 in
the NPCC group. In the PCC 6/
12 neonates were macrosomic
while 4/12 were macrosomic in
the NPCC group. HbA1c was
significantly lower in the first
trimester in the PCC group
compared to the NPCC group ,
(p < 0.01)
High (Both the study population
and the control were not
representative of the general
diabetic population with
frequency of diabetic vascular
complications approaching 50%.
The PCC components were not
defined neither the target blood
glucose)
Key: HbA1c = Glycosylated Hemoglobin A, PCC = Preconception Care, NPCC = No Preconception Care, OR = Odd Ratio, IDDM= Insulin depended Diabetes
Miletus, CI = Confidence Interval.
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Table 2 Characteristics of included retrospective cohort studies
Year of
Publication
(country)
Participants Intervention v comparison Outcome Risk of Bias
Dicker 1988
[15] (Israel)
59 IDDM women attended
a pre-conception clinic
compared to 35 pregnant
women who did not attend
PCC included: insulin and dietary
glycemic control, advice on
contraception and screening for
diabetes complications
PCC group had significantly
lower HA1C at the first trimester
(p < 0.001) and significantly
lower rate of spontaneous
abortion (p < 0.001) compared
to the NPCC group.
Low (Clear description of
participants and intervention,
noted confounding factors and
well presented results. There
was significant difference
between the two groups in the
diabetes complications before
intervention)
Dunne 1999
[16] (UK)
47 women with IDDM 12 of
them attended
preconception care clinic
and 35 women did not.
PCC included assessment of
diabetes complications and
glycemic control
The PCC group had significantly
lower level of HA1C level
compared to the NPCC group
(p < 0.008). There were no
congenital malformations in
both groups. The cesarean
section rate, the macrosomia
rate and the small for gestation
age were similar between the
two groups
Medium (Due to the audit
nature of the report there is no
clear description of the
intervention, some important
confounders were not
addressed such as White’s
classification and the outcome
assessment was not blinded )
Damm 1989
[14]
(Denmark)
197 attended PCC and 61
didn’t attend
PCC included: contraception and
glycemic control.
The rate of congenital
malformations was significantly
lower in the PPC group 1.0%
than the NPPC group 8.2%, (p <
0.01). No significant difference in
the level of HA1C during the first
trimester between the two
group
High (unclear description of the
participants, the intervention
and the outcome, the data of
the preconception care were a
subset of from different periods
of the study)
Goldman
1986 [21]
(Israel)
44 women with type I
diabetes attended the
preconception clinic and 31
women with type I diabetes
did not attend
PCC included assessment of
diabetic complications,
Contraception advice, Glycemic
control and dietary advice
The NPCC group had
significantly shorter duration of
pregnancy (p < 0.05)
significantly heavier mean birth
weight (p < 0.05) than the PCC
group. The two groups were
similar in neonatal
hypoglycemia, hypocalcaemia
and respiratory distress
syndrome
Low (Clear description of
participants and intervention,
noted confounding factors and
well presented results. There
was significant difference
between the two groups in the
diabetes complications before
intervention)
Fuhrmann
1986 [19] &
1984 [18] &
1983 [17]
(Germany)
620 pregnant women with
insulin dependent
diabetes,183 received pre-
pregnancy care 437 women
did not
PCC included: short
hospitalization every 3 month
until conception, education, self
monitoring of blood glucose,
assessment and treatment of
diabetes complications and
glycemic control
PCC group had significantly
lower rate of congenital
malformations 1.1% compared
to the NPCC group 7.0% (p <
0.01)
Medium (Well described
intervention, no blinding for the
outcome, no description of the
possible confounding factors)
Rowe 1987
[27] (UK)
21 IDDM 14 received
preconception care and 7
did not
PCC included Glycemic control,
counseling and blood glucose
self monitoring
The PCC group had significantly
better initial HA1C level (p <
0.0001), and lower mean birth
weight (p < 0.05)
High (Unclear description of the
participants, no description of
possible confounding factors,
no blinding in assessment of
the outcome, small group, high
target of HbA1C 5-9%)
Steel 1990
[28] & 1982
[31] (UK-
Scotland)
143 IDDM women attended
the preconception care
clinic and 96 IDDM women
did not attend
PCC included: education,
glycemic controlled and
contraception
PCC group had lower initial
HbA1C as compared to NPCC
group (p < 0.0001) and lower
rate of congenital mal
formations (p < 0. 005) ,
maternal hypoglycemia was
significantly common in the
PCC group than the NPCC (p <
0. 001)
Medium (Good description of
interventions, contamination of
the control who might know
about the usefulness of the and
the outcome assessment was
not blinded )
Key: HbA1C = Glycosylated Hemoglobin A, PCC = Preconception Care NPCC = No Preconception Care, OR = Odd Ratio, IDDM = Insulin depended Diabetes
Miletus.
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The evidence did not support the effectiveness of
the PCC in reducing, spontaneous abortion, pre-
eclampsia, cesarean delivery, macrosomia, RDS, SGA
and neonatal hypoglycemia (Table 5 and Additional
file 1:Appendix 3).
The use of multivitamins in the preconception period
as a sole intervention, was evaluated by one case control
study [13] and was found not to be effective in reducing
the rate of congenital malformations (Odd Ratio (OR)
0.15 95% CI 0.00-1.99).
Similarly one study, at high risk of bias, evaluated the
effectiveness of preconception counseling, as a sole inter-
vention, in improving fetal and neonatal outcomes, showed
improvement in total mortality (still birth and neonatal
death) and the rate of congenital malformation [30].
Hypoglycemia as adverse effect of PCC was evaluated
by two studies [10,28]. Meta-analysis of the pooled data
did not show difference between the PCC and the con-
trol group (Figure 7).
Data were not available for the evaluation of the effects
of PCC on polyhydramninos, termination of pregnancy
for congenital malformations, induction of labor, birth
trauma, shoulder dystocia and admission to NICU.
Discussion
Our systematic review of the effectiveness of PCC in the
improvement of maternal and fetal outcomes, found
sufficient evidence to support its implementation in
practice.
The nature of the intervention lent strength to the
observational studies by avoiding certain biases known
to occur in such study designs. Lack of allocation con-
cealment and blinding of participants were avoided by
recruiting the intervention and the control groups at dif-
ferent times during the course of the study (preconcep-
tion period and antenatal period). Due to the relatively
short duration of the pregnancy, attrition bias was noted
in only one study, [26] all other studies had complete
follow up of both groups. However the problem of con-
founding factors such as smoking, maternal age, parity
and vascular complications of diabetes, was noted by
most of the studies but only one study used the appro-
priate statistical test to quantify the effect of the PCC
apart from the confounders [10].
The homogeneity of the participants, the intervention
and the outcomes gives confidence in the estimated
effects of the PCC from the pooled data.
The effectiveness of PCC in reducing congenital malfor-
mations is impressive (Table 5 and Figure 2) and has prac-
tical implication considering the recent report of the
CEMCH [4] which showed that congenital malformations
rate in infants of diabetic mothers in England, Wales and
Northern Ireland is more than twice the background
population rate. This finding is also of a paramount
Table 3 Characteristics of included case-control studies
Study/Year
of
Publication
(country)
Participants Intervention Outcome Risk of Bias/Notes
Correa
2003 [13]
USA
Cases were 3278 Infants with
congenital malformations related to
diabetes. Controls were 3029 infants
without congenital malformations.
Maternal diabetes and intake of
multivitamin were evaluated as a risk
factors for congenital malformations
PCC included the
use of
multivitamin for
3 month before
conception
The risk of congenital malformations
related to diabetes was limited to
infants of f diabetic mothers who had
not taken multivitamin (OR 3.39 95%
CI 1.79-8.63). Mother who had taken
multivitamin had no increase risk of
congenital malformations related to
diabetes (OR 0.15 95% CI 0.00-1.99)
Medium (clear definition and
selection of cases and controls, and
outcomes, clearly defined outcome,
not clear if the interviewers were
blinded to the outcome, recall bias
cannot be excluded during the
interviews)
Key: OR= Odd Ratio, CI= Confidence Interval.
Table 4 Characteristics of included controlled trials
Study/Year of Publication
(country)
Participants Intervention
v
comparison
Outcome Risk of Bias/Note
Pregnancy outcome in
Diabetes control and
complication trial research
group 1996 [12] (USA)
187 had
preconception
intensive insulin
therapy and 83
did not.
PCC included
glycemic
control and
dietary advice.
There were 26 spontaneous abortion in
the PCC group and 16 in the NPCC
group. One still birth in the PCC group
and 3 in the NPCC. Congenital mal
formations were 5in the PCC group and 4
in the NPCC group. No differences on
neonatal morbidity or maternal
morbidity. Mean HbA1C in PCC group
=7.4 ± 1.3 and in NPCC = 8.8 ± 1.7
High (Unclear report of the outcome,
the control group was aware of the
importance of glycemic control and
was repeatedly advised to change into
intensive therapy when planning
pregnancy. So intervention was not
restricted to the preconception group.
No specific target level of the blood
sugar was stated for the preconception
group)
Key: HbA1C = Glycosylated Hemoglobin A, PCC = Preconception Care, NPCC = No Preconception Care.
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Figure 2 Risk ratio for congenital malformations from 11 studies of women with preexisting diabetes mellitus who did or did not
receive preconception care. PCC= the group who received preconception care; NPCC= the group who did not received preconception care;
CI= Confidence intervals.
Table 5 Pooled estimates effect of preconception care
Dichotomous outcomes of preconception care No of studies [references] Risk Ratio (95%Confedance interval)
Congenital malformation 11 [10,16,19-21,23,25,26,28,32,33] 0.25(0.15,0.42)
Perinatal Mortality 5 [10,16,20,23,33] 0.35(0.15,0.82)
Macrosomia 3 [10,20,23] 1.03(0.81,1.30)
Cesarean Section 5 [10,16,20,21,23] 1.08(0.96,1.22)
Preterm Delivery 4 [10,16,20,23] 0.7 (0.55,0.90)
Pre-eclampsia 3 [10,20,21] 0.92(0.62,1.35)
Neonatal Hypoglycemia 3 [20,21,23] 0.65(0.39,1.08)
Maternal Hypoglycemia 2 [10,28] 1.51(1.15,1.99)
Spontaneous Abortion 7 [10,15,20,23,25,26,32] 0.78(0.55,1.11)
Respiratory Distress Syndrome 3 [20,21,23] 0.55(0.26,1.16)
Small for Gestation Age 2 [20,23] 0.26(0.05,1.41)
Continuous outcomes Number of studies ( references) Means difference (95% CI)
The difference in the level of glycosylated Hemoglobin A1c 4 [10,21,26,28] 2.43(2.27,2.58)
The difference in gestational age at first visit to antenatal care 3 [10,23,26] 1.32 (1.23, 1.40)
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Figure 3 Risk ratio for preterm delivery from 4 studies of women with preexisting diabetes mellitus who did or did not receive
preconception care. PCC= Preconception care; NPCC= No preconception care; CI= Confidence intervals.
Figure 4 Risk ratio for perinatal mortality from 5 studies of women with preexisting diabetes mellitus who did or did not receive
preconception care. PCC= the group who received preconception care; NPCC= the group who did not received preconception care; CI=
Confidence intervals.
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Figure 5 First trimester mean value of glycosylated hemoglobin from 4 studies of women with preexisting diabetes mellitus who did
or did not receive preconception care. PCC= Preconception care; NPCC= No preconception care; CI= Confidence intervals
Figure 6 The mean gestation age at the time of the first antenatal visit from 3 studies of women with preexisting diabetes mellitus
who did or did not receive preconception care. PCC= Preconception care; NPCC= No preconception care; CI= Confidence intervals.
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importance to many communities in the Middle East [35],
North Africa [36] and some communities in Asia [37]
where the burden of congenital malformation is very high
due to many causes including maternal diabetes.
The effect of PCC in reducing the rate of congenital
malformations reflected positively on its effect in redu-
cing the perinatal mortality among women who utilized
the care (Figure 4). This effect addresses a major health
problem of four folds increase in the perinatal mortality
in mothers with preexisting diabetes when compared to
the general population [38]
The meta-analysis supported the effectiveness of the
PCC in reducing the rate of preterm delivery (Table 5
and Figure 3). We believe that effect would have been
larger if data were available for very preterm delivery
≤34 weeks of gestation when the effect of the precon-
ception rather than the antenatal care is evaluated as
demonstrated by one study [10].
Maternal hyperglycemia during the period of organo-
genesis is known to be associated with congenital mal-
formations [39,40]. The analysis of the pooled data in
this review suggested that PCC is effective in reducing
the level of HbA1C during the first trimester of preg-
nancy and hence the risk of congenital malformations
(Table 5 and Figure 5).
We were surprised that meta-analysis did not support
the effectiveness of PCC in improving the rates of sponta-
neous abortion (Table 5 and Additional file 1: Appendix 3).
We suggest that this result is due to late attendance of the
control group for antenatal care by which time some
events of spontaneous abortion might have been missed.
This suggestion was further supported by meta-analysis of
the gestation age at first visit for the PCC and the control
groups, (Figure 6) which showed significant difference
between the two groups.
In this review one case control study addressed the
effectiveness of multivitamins supplementation in the
preconception period, as an isolated intervention, in
reducing the rate of congenital malformations[13]. The
role of folic acid and multivitamins in the prevention of
some congenital malformation is well documented [41].
However all other studies included in this review, except
for one recent report [10], did not include multivitamin
or folic acid in their program of PCC, which supports
an expectation of larger effect of PCC in improving fetal
and neonatal outcomes if folic acid or multivitamin sup-
plementation becomes an integral part of that care.
Another isolated preconception intervention proved to
be effective in improving fetal and neonatal outcomes, is
women counseling, an intervention evaluated by only
one study [30]
Other outcomes which did not improve by PCC, such
as pre-eclampsia, cesarean delivery and macrosomia
(Table 5 and Additional file 1: Appendix 3), might be
related to care during the latter part of pregnancy rather
than the preconception period. However few studies
were included in the meta-analysis for these outcomes
and further larger studies, with more participants might
prove the effectiveness of PCC in improving some or all
of these outcomes.
Figure 7 Risk ratio for maternal hypoglycemia from 2 studies of women with preexisting diabetes mellitus who did or did not receive
preconception care. PCC= Preconception care; NPCC= No preconception care; CI= Confidence intervals.
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Only two studies evaluated maternal hypoglycemia as
adverse effect of PCC [10,28] and the pooled data showed
no difference between the two groups (Figure 7). Marked
heterogeneity might be due to the differences in the tar-
get blood glucose level between the two studies.
One study conducted an economic evaluation of PCC
and found that it is associated with considerable saving
and reduced resources utilization [22] and yet population
based studies showed that only 34-38% of eligible women
receive PCC [4,30].
We suggest that more research is needed in methods
of encouraging diabetic women to utilize PCC.
Our review confirms previous findings by Ray et al [9].
The strength of our review comes from the comprehen-
sive evaluation of the available evidence on the effective-
ness and safety of PCC in improving maternal and fetal
outcomes together with assessment of wide range of
interventions which we considered as PCC and all the
possible maternal, fetal or neonatal outcomes which are
affected by maternal preexisting DM. However we are
aware of the limitation of the observations studies as the
sole source of evidence and the inherent bias associated
with the design of the cohort studies included in the
meta-analysis.
The review carries important implications for practice
and research as it highlights the importance of the inte-
gration of PCC in the routine care of diabetic women
during their reproductive age.
Conclusion
PCC for women with preexisting type 1 or type 2 DM is
effective in improving rates of congenital malformation,
perinatal mortality, preterm labour, level of maternal
HbA1c in the first trimester of pregnancy and maternal
early utilization of antenatal care.
Additional material
Additional files 1: Appendices Appendix 1: Search Strategy (the
systematic review search strategy). Appendix 2: Table of excluded studies
(description of studies excluded from the review and the reasons for
exclusion). Appendix 3: maternal and fetal outcomes not improved by
preconception care (Forest Plots of meta-analysis of outcomes which are
not improved by preconception care).
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